I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 9 studies | 46% ± 20% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 9 studies | 46% ± 20% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 29% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 7884.96 | 2640 / 2642 | 99% | 51.81 | 696 / 705 |
| prostate | 66% | 407.95 | 161 / 245 | 72% | 2.32 | 359 / 502 |
| uterus | 50% | 269.66 | 85 / 170 | 8% | 0.40 | 36 / 459 |
| bladder | 33% | 175.00 | 7 / 21 | 4% | 0.16 | 18 / 504 |
| adrenal gland | 2% | 6.43 | 4 / 258 | 32% | 1.10 | 73 / 230 |
| blood vessel | 25% | 149.32 | 328 / 1335 | 0% | 0 | 0 / 0 |
| kidney | 1% | 3.43 | 1 / 89 | 21% | 0.45 | 192 / 901 |
| skin | 0% | 1.41 | 7 / 1809 | 19% | 0.84 | 89 / 472 |
| ovary | 7% | 32.44 | 12 / 180 | 12% | 0.38 | 50 / 430 |
| esophagus | 11% | 44.76 | 153 / 1445 | 3% | 0.09 | 5 / 183 |
| heart | 13% | 48.50 | 108 / 861 | 0% | 0 | 0 / 0 |
| intestine | 3% | 18.76 | 33 / 966 | 6% | 0.15 | 34 / 527 |
| adipose | 9% | 36.86 | 103 / 1204 | 0% | 0 | 0 / 0 |
| breast | 3% | 14.18 | 16 / 459 | 4% | 0.11 | 46 / 1118 |
| thymus | 1% | 4.20 | 9 / 653 | 6% | 0.11 | 36 / 605 |
| stomach | 1% | 2.98 | 3 / 359 | 5% | 0.09 | 14 / 286 |
| lung | 1% | 3.96 | 7 / 578 | 4% | 0.12 | 43 / 1155 |
| tonsil | 0% | 0 | 0 / 0 | 4% | 0.11 | 2 / 45 |
| pancreas | 0% | 0 | 0 / 328 | 4% | 0.28 | 7 / 178 |
| muscle | 2% | 5.72 | 14 / 803 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 0% | 0.00 | 1 / 406 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0002052 | Biological process | positive regulation of neuroblast proliferation |
| GO_0001501 | Biological process | skeletal system development |
| GO_0010001 | Biological process | glial cell differentiation |
| GO_0085029 | Biological process | extracellular matrix assembly |
| GO_0007155 | Biological process | cell adhesion |
| GO_0008065 | Biological process | establishment of blood-nerve barrier |
| GO_0007417 | Biological process | central nervous system development |
| GO_0005615 | Cellular component | extracellular space |
| GO_0045202 | Cellular component | synapse |
| GO_0072534 | Cellular component | perineuronal net |
| GO_0031012 | Cellular component | extracellular matrix |
| GO_0033268 | Cellular component | node of Ranvier |
| GO_0005515 | Molecular function | protein binding |
| GO_0005540 | Molecular function | hyaluronic acid binding |
| Gene name | HAPLN2 |
| Protein name | Hyaluronan and proteoglycan link protein 2 Hyaluronan and proteoglycan link protein 2 (Brain link protein 1) |
| Synonyms | BRAL1 |
| Description | FUNCTION: Mediates a firm binding of versican V2 to hyaluronic acid. May play a pivotal role in the formation of the hyaluronan-associated matrix in the central nervous system (CNS) which facilitates neuronal conduction and general structural stabilization. Binds to hyaluronic acid (By similarity). . |
| Accessions | Q9GZV7 Q5T3J1 ENST00000255039.6 ENST00000708583.1 ENST00000456112.1 |
